Jim Simons Beam Therapeutics Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $2.23 Million - $3.13 Million	60,600 Added 84.99%	131,900 $5.16 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $8.3 Million - $14.7 Million	-208,600 Reduced 74.53%	71,300 $3.4 Million
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $8.36 Million - $17.5 Million	279,900 New	279,900 $10.8 Million
Q3 2021 Nov 12, 2021	SELL	$84.37 - $133.6 $1.39 Million - $2.2 Million	-16,500 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$64.12 - $128.71 $1.38 Million - $2.78 Million	-21,600 Reduced 56.69%	16,500 $2.12 Million
Q1 2021 May 13, 2021	BUY	$71.28 - $120.75 $2.72 Million - $4.6 Million	38,100 New	38,100 $3.05 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.